MeSH tree: D04.210.500.745.745.654.105
A multicenter clinical trial has found that intratracheal steroids do not reduce the risk of lung disease or death in extremely preterm infants, according to a study published in JAMA.
Nov 17, 2025
0
13
In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be more effective than salbutamol, ...
Sep 28, 2025
0
28
Findings from a first-of-its-kind virtual trial in pulmonary medicine, conducted at Rutgers and many other institutions, suggest adding an inhaled corticosteroid to rescue therapy could sharply reduce the danger of severe ...
May 19, 2025
0
39
Research led by the Royal Women's Hospital, Australia, has found that early intratracheal administration of budesonide mixed with surfactant may have little to no effect on improving survival free of bronchopulmonary dysplasia ...
A comparison of treatments for malnutrition enteropathy, caused by severe acute malnutrition (SAM), has found evidence supporting the use of treatments to enhance the healing of mucosal membranes and reduce inflammation in ...
Apr 17, 2024
0
36
Eosinophilic esophagitis (EoE) is an allergic inflammatory disorder that affects the esophagus, causing distressing symptoms such as difficulty swallowing in adolescents and adults, and vomiting and abdominal pain in children.
Feb 27, 2024
0
44
It's a hidden cause of diarrhea, and the development of the disease is poorly understood. Multiple factors work against the diagnosis of microscopic colitis, an inflammatory digestive disease, because the symptom distress ...
Dec 13, 2023
0
32
In 1976, a Swedish pathologist, C.G Lindström, published a paper describing a colonic anomaly. Through his microscope, he noted that part of the large intestinal wall of one of his patients was thickened. The patient, whose ...
Dec 13, 2023
0
39
For patients with immunoglobulin A (IgA) nephropathy, nine months of treatment with targeted-release formulation of budesonide (Nefecon) yields a greater reduction in estimated glomerular filtration rate (eGFR) than placebo, ...
Aug 22, 2023
0
40
For high-risk outpatients with COVID-19, treatment with oral fluvoxamine plus budesonide reduces the incidence of severe disease needing advanced care, according to a study published online April 18 in the Annals of Internal ...
Apr 18, 2023
0
33
